- Home
- CGTX vs INO Comparison
CGTX vs INO Comparison
Compare CGTX & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- INO
- Stock Information
- Founded
- CGTX 2007
- INO 1979
- Country
- CGTX United States
- INO United States
- Employees
- CGTX N/A
- INO 134
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- INO Medical/Dental Instruments
- Sector
- CGTX Health Care
- INO Health Care
- Exchange
- CGTX Nasdaq
- INO Nasdaq
- Market Cap
- CGTX 126.2M
- INO 128.1M
- IPO Year
- CGTX 2021
- INO 1998
- Fundamental
- Price
- CGTX $1.70
- INO $2.37
- Analyst Decision
- CGTX Strong Buy
- INO Buy
- Analyst Count
- CGTX 3
- INO 5
- Target Price
- CGTX $2.83
- INO $8.80
- AVG Volume (30 Days)
- CGTX 3.3M
- INO 1.1M
- Earning Date
- CGTX 11-12-2025
- INO 11-13-2025
- Dividend Yield
- CGTX N/A
- INO N/A
- EPS Growth
- CGTX N/A
- INO N/A
- EPS
- CGTX N/A
- INO N/A
- Revenue
- CGTX N/A
- INO $182,337.00
- Revenue This Year
- CGTX N/A
- INO N/A
- Revenue Next Year
- CGTX N/A
- INO $15,960.33
- P/E Ratio
- CGTX N/A
- INO N/A
- Revenue Growth
- CGTX N/A
- INO N/A
- 52 Week Low
- CGTX $0.22
- INO $1.30
- 52 Week High
- CGTX $3.83
- INO $5.83
- Technical
- Relative Strength Index (RSI)
- CGTX 52.47
- INO 54.07
- Support Level
- CGTX $1.29
- INO $2.38
- Resistance Level
- CGTX $1.61
- INO $2.58
- Average True Range (ATR)
- CGTX 0.14
- INO 0.14
- MACD
- CGTX -0.01
- INO -0.03
- Stochastic Oscillator
- CGTX 93.62
- INO 51.95
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.